期刊文献+

联合p504S、VEGF、p63检测在前列腺良恶性病变鉴别诊断中的应用 被引量:1

Application of p504S,vascular endothelial growth factor and p63 in the differential diagnosis of benign and malignant lesions of the prostate
下载PDF
导出
摘要 目的:探讨联合p504S、VEGF、p63检测在前列腺良、恶性病变鉴别诊断中的应用。方法:采用微波S-P免疫组化方法,观察p504S、VEGF、p63在前列腺良、恶性病变中的表达情况。结果:大多数良性前列腺增生的腺泡和导管周围可见连续的p63表达,少数呈间断表达,但p504S均皆呈阴性,大多数良性前列腺增生患者VEGF呈阴性;高级别上皮内瘤p63呈不连续表达,p504S呈弱阳性或阴性,VEGF呈阴性或弱阳性;7例非典型腺瘤性增生,p63均呈阳性;40例前列腺癌,p63均呈阴性,p504S均呈阳性;前列腺癌Gleason分级与p504S免疫表达无关,但与VEGF表达有关。结论:联合检测p504S、VEGF、p63可提高前列腺癌诊断的准确率,尤其适合于体积较小的前列腺穿刺标本进行良、恶性鉴别。 Objective Tc cvaluate the value of p504S, vascular endothelial growth factor and p63 immunostaining for the diagnosis of benign and malignant lesions of the prostate. Methods The expressions of p504S, vascular endothelial growth factor and p63 in benign and malignant lesions of the prostate were observed by microwave SP immunohistochemical method. Results Continuous positive expression of p63 was found in the acini and ducts of most benign prostatic hyperplasia, and few cases showed interrupted expression, but p504S staining presented negative reaction. Interrupted expression of p63 was found in high prostatic intraepithelial neoplasia cases, and was weakly positive or negative for p504S; p63 staining was positive in 5 atypical adenomatous hyperplasia cases, 1 case presented focally positive reaction by p504S; p63 staining was negative in 40 prostatic carcinoma, but positive by p504S; The gleason histologic grading of prostate carcinoma was not related to the expression of p504S but related with vascular endothelial growth factor. Conclusion The combined detection of p504S, vascular endothelial growth factor and p63 can be the most helpful for the diagnosis of prostate carcinoma, especially in needle biopsy specimen.
出处 《实用诊断与治疗杂志》 2008年第5期332-334,共3页 Journal of Practical Diagnosis and Therapy
关键词 前列腺肿瘤 鉴别诊断 免疫组化 P504S VEGF P63 Prostatic neoplasia differential diagnosis immunohistochemistry p504S vascular endothelial growth factor p63
  • 相关文献

参考文献12

  • 1Jemal A, Tiwari R C, Murray T, et al. Cancer statistics[J]. Ca Cancer J Clin,2004,54(1) :8.
  • 2上海市肿瘤研究所流行病学研究室.2000年上海市恶性肿瘤发病率[J].肿瘤,2003,23:532-532.
  • 3Bubendof L, Schopfer A, Wagner U, et al. Metastasis patterns of prostate cancer: an autopsy study of 1589 patients[J]. Hum Pathol,2000,31(5) :578-581.
  • 4张子杰,李印.CK34βE12、P63和PSA、P504S在前列腺穿刺诊断中的应用[J].实用诊断与治疗杂志,2007,21(5):389-390. 被引量:3
  • 5侯振江,张宗英.血管内皮生长因子及其受体检测在恶性肿瘤诊疗中的应用[J].诊断学理论与实践,2005,4(1):86-88. 被引量:18
  • 6Epstein J I, Allsbrook W C Jr, Amin M B, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatis Carcinoma[J]. Am J Surg Pathol, 2005,29(9) :1228-1242.
  • 7蔡振,周华设.比卡鲁胺治疗晚期前列腺癌对血清PSA、f-PSA含量影响[J].实用诊断与治疗杂志,2006,20(6):401-402. 被引量:2
  • 8Xu J, Stolk J A, Zhang X, et al. Indentifieation of differentially expressed genes in human prostate cancer using subtraction and microarray [J]. Cancer Res,2000,60(6) : 1677-1682.
  • 9Jiang Z, Woda B A, Rock K L, et al. P504s: a new molecular marker for the detection of prostate carcinoma[J]. Am J Surg Pathol, 2001,25( 11 ) : 1397-1404.
  • 10Luo J, Zha S, Gage W R, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer[J].Cancer Res,2002,62(8) :2220-2226.

二级参考文献35

  • 1孔祥田,邓方明,王静华,宓培,苏晋伟,夏同礼,郭应禄,顾方六.高分子量细胞角蛋白在前列腺腺癌鉴别诊断中的应用[J].中华病理学杂志,1996,25(4):199-201. 被引量:19
  • 2[1]Migdal M, Huppertz B, Tessler S, et al. Neuropilin-1 is a placenta growth factor- 2 receptor[J]. J Biol Chem, 1998,273(35):22272-22278.
  • 3[2]Takanami I, Tanaka F, Hashizume T, et al. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma[J].Anti cancer Res, 1997,17(4A):2811-2814.
  • 4[4]Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer[J]. Eur J Cancer, 2001,37(7):918-923.
  • 5[9]Tang RF, Itakura J, Aikawa T, et al. Overexpression of lymphangiogenie growth factor VEGF-C in human pancreatic cancer[J]. Pancreas, 2001,22(3):285-292.
  • 6[11]Latil A, Bieche I, Pesche S, et al. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms[J]. Int J Cancer, 2000,89(2):167-171.
  • 7[12]Hazelton D, Nicosia RF, Nicosia SV. VEGF levels in ovarian cyst fluid correlate with malignancy[J]. Clin Cancer Res, 1999,5(4):823-829.
  • 8[13]Gadducci A, Ferdeghini M, Fanucchi A, et al. Serum preoperative VEGF in epithelial ovarian cancer relationship prognostic variables and clinical outcome [J]. Anticancer Res, 1999,19(2B):1401-1405.
  • 9[14]Giatromanolaki A, Sivridis E, Brekken R, et al. The angiogenic "vascular endothelial growth factor/flk-1 (KDR)receptor"pathway in patients with endometrial carcinoma [J]. Cancer, 2001,92(10):2569-2577.
  • 10[16]Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies [J]. Cancer Res, 1999,59(3):728-733.

共引文献62

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部